Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study
- PMID: 19379620
- DOI: 10.2500/ajra.2009.23.3269
Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study
Erratum in
- Am J Rhinol Allergy. 2009 Mar-Apr;23(2):238. Kassam, Amin Bardai [added]; Morcos, Jacques J [added]
Abstract
Background: This study reports the combined experience of the University of Miami and University of Pittsburgh with endoscopic endonasal resection of esthesioneuroblastoma (ENB). A retrospective case series review was performed in a tertiary care university hospital.
Methods: Twenty-three patients, 16 men and 7 women, were reviewed. Mean age was 56.6 years (15-79 years). Nineteen patients received primary endoscopic endonasal anterior skull base resection. Of these, the modified Kadish stage at presentation was A in 2 patients, B in 11 patients, C in 5 patients, and D in 1 patient. Three patients had revision surgeries for recurrent tumors. The main outcome measures were complete resection and margin assessment, short-term and long-term complications, and recurrence rate.
Results: Complete resection and negative intraoperative resection margins were achieved endoscopically in 17 of the primarily treated cases. The two other cases had one patient that required an additional craniotomy approach to complete the resection of a positive lateral dual margin, another patient had positive margins at the orbital apex. All patients tolerated the endoscopic procedure very well with no meningitis. There were four cerebral spinal fluid leaks. Mean follow-up period for the primarily treated cases was 45.2 months (11-152 months), all were disease free at the most recent available follow-up.
Conclusion: In experienced hands and carefully selected patients, endoscopic resection of ENB respects the principles of oncologic surgery, providing an adequate exposure for margin assessment as well as reliable reconstruction of the anterior skull defect with a relatively low morbidity.
Similar articles
-
Transnasal, transfacial, anterior skull base resection of olfactory neuroblastoma.Am J Otolaryngol. 2011 Jul-Aug;32(4):279-85. doi: 10.1016/j.amjoto.2010.05.003. Epub 2010 Aug 21. Am J Otolaryngol. 2011. PMID: 20728963
-
Endoscopic resection of esthesioneuroblastoma.J Clin Neurosci. 2012 Nov;19(11):1478-82. doi: 10.1016/j.jocn.2012.03.011. Epub 2012 Sep 18. J Clin Neurosci. 2012. PMID: 22995757
-
Endoscopic resection of esthesioneuroblastoma.Am J Rhinol. 2001 Jul-Aug;15(4):271-9. Am J Rhinol. 2001. PMID: 11554661 Review.
-
Endoscopic-assisted craniofacial resection of esthesioneuroblastoma: minimizing facial incisions--technical note and report of 3 cases.Minim Invasive Neurosurg. 2003 Oct;46(5):310-5. doi: 10.1055/s-2003-44452. Minim Invasive Neurosurg. 2003. PMID: 14628249
-
Endoscopic management of Esthesioneuroblastoma: Our experience and review of the literature.J Clin Neurosci. 2018 Dec;58:117-123. doi: 10.1016/j.jocn.2018.09.011. Epub 2018 Oct 16. J Clin Neurosci. 2018. PMID: 30340976 Review.
Cited by
-
Bilateral Synchronous Ectopic Ethmoid Sinus Olfactory Neuroblastoma: A Case Report.Am J Case Rep. 2016 Apr 21;17:268-73. doi: 10.12659/ajcr.897623. Am J Case Rep. 2016. PMID: 27097989 Free PMC article.
-
Endoscopic endonasal technique: treatment of paranasal and anterior skull base malignancies.Braz J Otorhinolaryngol. 2013 Nov-Dec;79(6):760-79. doi: 10.5935/1808-8694.20130138. Braz J Otorhinolaryngol. 2013. PMID: 24474490 Free PMC article. Review.
-
Synchronous esthesioneuroblastoma and growth-hormone-secreting pituitary macroadenoma: combined open and endoscopic management.J Neurol Surg Rep. 2014 Dec;75(2):e194-9. doi: 10.1055/s-0034-1372472. Epub 2014 Jul 21. J Neurol Surg Rep. 2014. PMID: 25485212 Free PMC article.
-
Delaying Postoperative Radiotherapy in Low-Grade Esthesioneuroblastoma: Is It Worth the Wait?J Neurol Surg B Skull Base. 2021 Jul;82(Suppl 3):e166-e171. doi: 10.1055/s-0040-1708854. Epub 2020 Mar 25. J Neurol Surg B Skull Base. 2021. PMID: 34306932 Free PMC article.
-
Long-Term Survival Outcomes and Treatment Experience of 64 Patients With Esthesioneuroblastoma.Front Oncol. 2021 Mar 4;11:624960. doi: 10.3389/fonc.2021.624960. eCollection 2021. Front Oncol. 2021. PMID: 33747939 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous